Patents by Inventor Taichi Takahashi

Taichi Takahashi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230012495
    Abstract: A cushion material with improved vibration absorptivity, and a cushion material manufacturing method for easily obtaining the cushion material are provided. The cushion material (1) includes a foam body (2) having a surface portion (20) formed of an air permeability control surface portion (21) and an air permeability uncontrol surface portion (22), and a covering material (3) configured to cover the air permeability uncontrol surface portion (22). The cushion material manufacturing method is a cushion material manufacturing method for obtaining the cushion material (1), and includes covering the air permeability uncontrol surface portion (22) of the foam body (2) with the covering material (3).
    Type: Application
    Filed: December 7, 2020
    Publication date: January 19, 2023
    Applicant: BRIDGESTONE CORPORATION
    Inventors: Taichi ITABASHI, Yukiko YAMAGUCHI, Satoshi IENAGA, Yoshiyuki TAKAHASHI
  • Publication number: 20220369828
    Abstract: A seat pad with improved thermal comfort and improved vibration absorptivity and a seat pad manufacturing method for easily obtaining the seat pad are provided. In the seat pad (1), when a surface portion (2) up to 10 mm from a surface (1f) is cut out and the air permeability AR1 of the surface portion (2) is measured in compliance with JIS K 6400, the air permeability AR1 is more than 5 cc/cm2/sec and 25 cc/cm2/sec or less. The seat pad manufacturing method is a seat pad manufacturing method for obtaining the seat pad (1) by supplying a molding material into a molding die and performing foam molding. As the molding die, a molding die an inner surface of which is covered with polystyrene or polyethylene is used.
    Type: Application
    Filed: December 8, 2020
    Publication date: November 24, 2022
    Applicant: BRIDGESTONE CORPORATION
    Inventors: Yukiko YAMAGUCHI, Yoshiyuki TAKAHASHI, Taichi ITABASHI
  • Patent number: 11505214
    Abstract: A driving operation handover system includes a memory and a processor, wherein the processor is configured to: acquire a first characteristic value of preset setting characteristics during travel of a vehicle equipped with a manual operation unit that an occupant operates; acquire a second characteristic value of the preset setting characteristics during travel of a virtual vehicle that simulates the vehicle, which a remote operator operates using a remote operation unit; calculate a difference value between the first characteristic value and the second characteristic value; in a case in which the difference value is lower than a setting threshold value, notify the occupant and the remote operator that operation of the vehicle can be handed over; and after notification, switch operation of the vehicle from one of the remote operator or the occupant to another of the remote operator or the occupant.
    Type: Grant
    Filed: June 30, 2020
    Date of Patent: November 22, 2022
    Assignee: TOYOTA JIDOSHA KABUSHIKI KAISHA
    Inventors: Yosuke Tokuda, Masahiro Nishio, Shuichiro Takahashi, Haruka Yano, Taichi Amakasu
  • Patent number: 11479266
    Abstract: A remote operation system includes a processor that is configured to acquire position information and communication quality information from each of plural vehicles on a regular basis, create position-specific communication quality information in which the position information and the communication quality information are associated with each other, supply the position-specific communication quality information to an operator of a remote operation target vehicle.
    Type: Grant
    Filed: May 21, 2020
    Date of Patent: October 25, 2022
    Assignee: TOYOTA JIDOSHA KABUSHIKI KAISHA
    Inventors: Yosuke Tokuda, Masahiro Nishio, Shuichiro Takahashi, Haruka Yano, Taichi Amakasu
  • Publication number: 20220298118
    Abstract: Provided is a compound superior in an ATX inhibitory action and useful for the prophylaxis or treatment of diseases involving ATX. A carboxylic acid compound represented by the following formula (1) or a pharmacologically acceptable salt thereof: wherein each symbol is as defined in the SPECIFICATION.
    Type: Application
    Filed: July 26, 2019
    Publication date: September 22, 2022
    Applicant: MITSUBISHI TANABE PHARMA CORPORATION
    Inventors: Taichi TAKAHASHI, Hisayuki TAKAMATSU, Daisuke llJIMA, Shuzo TAKEDA
  • Publication number: 20220246905
    Abstract: Provided are a negative electrode that is for use in a non-aqueous electrolyte secondary battery, includes a porous metal body as a current collector, contains a skeleton-forming agent highly infiltrated in the current collector so that It is less likely to suffer from structural degradation and provides improved cycle durability; and a non-aqueous electrolyte secondary battery including such a negative electrode. The negative electrode for use in a non-aqueous electrolyte secondary battery includes a current collector including a porous metal body; a first negative electrode material disposed in pores of the porous metal body and including a conductive aid, a binder, and a negative electrode active material including a silicon-based material; and a second negative electrode material disposed in pores of the porous metal body and including a skeleton-forming agent including a silicate having a siloxane bond.
    Type: Application
    Filed: January 27, 2022
    Publication date: August 4, 2022
    Inventors: Kiyoshi Tanaami, Toshimitsu Tanaka, Yuji Isogai, Makiko Takahashi, Shintaro Aoyagi, Takashi Mukai, Yuta Ikeuchi, Taichi Sakamoto, Naoto Yamashita
  • Publication number: 20220246919
    Abstract: To provide a negative electrode for nonaqueous electrolyte secondary batteries, by which durability deterioration and structural deterioration of the electrode is suppressed, and cycle durability and energy density can be improved by suppressing generation of voids in the inside of the porous metal, and a nonaqueous electrolyte secondary battery including the same. A negative electrode for nonaqueous electrolyte secondary batteries, having a current collector made of porous metal, and a negative electrode material placed in pores of the porous metal, the negative electrode material including a first negative electrode active material placed on an internal surface of each of the pores and including a silicon-based material; a skeleton forming agent placed on the first negative electrode active material and including a silicate having a siloxane bond; and a second negative electrode active material placed on the skeleton forming agent.
    Type: Application
    Filed: January 27, 2022
    Publication date: August 4, 2022
    Inventors: Kiyoshi TANAAMI, Toshimitsu TANAKA, Yuji ISOGAI, Makiko TAKAHASHI, Shintaro AOYAGI, Takashi MUKAI, Yuta IKEUCHI, Taichi SAKAMOTO, Naoto YAMASHITA
  • Publication number: 20220231299
    Abstract: To provide a nonaqueous electrolyte secondary battery which enables to suppress durability deterioration, improve energy density, and further suppress a decrease in the function of the nonaqueous electrolyte secondary battery cell. A nonaqueous electrolyte secondary battery, comprising: a positive electrode; and a negative electrode, wherein the negative electrode has: a current collector comprising a porous metal body; and a negative electrode material disposed in pores of the porous metal body, the negative electrode material comprises a negative electrode active material comprising a silicon-based material, a skeleton-forming agent comprising a silicate having a siloxane bond, a conductive auxiliary, and a binder, and a content of the skeleton-forming agent in an outside in a surface direction of the negative electrode is higher than a content of the skeleton-forming agent in an inside in the surface direction of the negative electrode.
    Type: Application
    Filed: January 19, 2022
    Publication date: July 21, 2022
    Inventors: Kiyoshi Tanaami, Toshimitsu Tanaka, Yuji Isogai, Shintaro Aoyagi, Makiko Takahashi, Tomohiro Kinoshita, Takashi Mukai, Yuta Ikeuchi, Taichi Sakamoto, Naoto Yamashita
  • Patent number: 11386588
    Abstract: A product design system includes a first transmitting section that uses a look-up table to convert second design image data for which image correction is completed into third design image data of a color space that is represented with a thermochromic material, and transmits the third design image data derived from the conversion to an external apparatus, and a second transmitting section that transmits a decorating request based on fourth design image data that is profile-transformed from the second design image data to a decorating apparatus.
    Type: Grant
    Filed: November 17, 2017
    Date of Patent: July 12, 2022
    Assignee: SONY CORPORATION
    Inventors: Asuka Tejima, Yuki Oishi, Masaru Wada, Kenichi Kurihara, Satoko Asaoka, Yuriko Kaino, Nobukazu Hirai, Yusuke Kajio, Aya Shuto, Taichi Takeuchi, Isao Takahashi
  • Publication number: 20220216249
    Abstract: Imaging devices and electronic apparatuses incorporating imaging devices or image pick-up elements are provided. An imaging device as disclosed can include a substrate, a first opto-electronic converter having a first area formed in the substrate, and a second opto-electronic converter having a second area formed in the substrate. The first area is larger than the second area. In addition, a light blocking wall can extend from a first surface of the substrate such that at least a portion of the light blocking wall is between the first opto-electronic converter and the second opto-electronic converter.
    Type: Application
    Filed: January 12, 2022
    Publication date: July 7, 2022
    Applicant: SONY SEMICONDUCTOR SOLUTIONS CORPORATION
    Inventors: Takeshi YANAGITA, Taichi NATORI, Hirotsugu TAKAHASHI, Shunsuke MARUYAMA, Yasushi MARUYAMA
  • Patent number: 9783522
    Abstract: Provided is a compound superior in an autotaxin inhibitory action and the like, effective as a prophylactic or therapeutic drug for diseases involving ATX. The present invention relates to a compound represented by the following formula (I): [wherein each symbol is as described in the DESCRIPTION], which has a superior autotaxin inhibitory action and is useful as a prophylactic or therapeutic drug for diseases involving ATX.
    Type: Grant
    Filed: April 24, 2015
    Date of Patent: October 10, 2017
    Assignee: MITSUBISHI TANABE PHARMA CORPORATION
    Inventors: Taichi Takahashi, Akinori Umino, Daisuke Iijima, Hisayuki Takamatsu
  • Publication number: 20170044133
    Abstract: Provided is a compound superior in an autotaxin inhibitory action and the like, effective as a prophylactic or therapeutic drug for diseases involving ATX. The present invention relates to a compound represented by the following formula (I): [wherein each symbol is as described in the DESCRIPTION], which has a superior autotaxin inhibitory action and is useful as a prophylactic or therapeutic drug for diseases involving ATX.
    Type: Application
    Filed: April 24, 2015
    Publication date: February 16, 2017
    Applicant: MITSUBISHI TANABE PHARMA CORPORATION
    Inventors: Taichi TAKAHASHI, Akinori UMINO, Daisuke IIJIMA, Hisayuki TAKAMATSU
  • Patent number: 8791266
    Abstract: Provided is a heterocyclic derivative showing a thyroid hormone ? receptor agonist action, which is effective for the prophylaxis or treatment of the diseases relating to the action. A compound represented by the formula [I]: wherein each symbol is as defined in the specification, a pharmacologically acceptable salt thereof, and a medicament containing the compound as an active ingredient.
    Type: Grant
    Filed: April 19, 2010
    Date of Patent: July 29, 2014
    Assignee: Mitsubishi Tanabe Pharma Corporation
    Inventors: Shinji Kawata, Koji Matsumoto, Maki Niijima, Taichi Takahashi
  • Patent number: 8748620
    Abstract: Provided is a heterocyclic derivative showing a thyroid hormone ? receptor agonist action, which is effective for the prophylaxis or treatment of the diseases relating to the action. A compound represented by the formula [I]: wherein each symbol is as defined in the specification, a pharmacologically acceptable salt thereof, and a medicament containing the compound as an active ingredient.
    Type: Grant
    Filed: April 19, 2010
    Date of Patent: June 10, 2014
    Assignee: Mitsubishi Tanabe Pharma Corporation
    Inventors: Shinji Kawata, Koji Matsumoto, Maki Niijima, Taichi Takahashi
  • Publication number: 20120129812
    Abstract: Provided is a heterocyclic derivative showing a thyroid hormone ? receptor agonist action, which is effective for the prophylaxis or treatment of the diseases relating to the action. A compound represented by the formula [I]: wherein each symbol is as defined in the specification, a pharmacologically acceptable salt thereof, and a medicament containing the compound as an active ingredient.
    Type: Application
    Filed: April 19, 2010
    Publication date: May 24, 2012
    Applicant: MITSUBISHI TANABE PHARMA CORPORATION
    Inventors: Shinji Kawata, Koji Matsumoto, Maki Nijima, Taichi Takahashi
  • Patent number: 7501412
    Abstract: The present invention relates to an isoquinoline compound represented by the following formula (I) or (II), an optically active form thereof, a pharmaceutically acceptable salt thereof, a water adduct thereof, a hydrate thereof and a solvate thereof, as well as an agent for the prophylaxis and/or treatment of a disease caused by hyperreactivity of poly(ADP-ribose)polymerase, containing the compound, and a poly(ADP-ribose)polymerase inhibitor containing the compound. In addition, this compound is useful as an agent for the prophylaxis and/or treatment of cerebral infarction, particularly as an agent for the prophylaxis and/or treatment of acute cerebral infarction.
    Type: Grant
    Filed: November 21, 2003
    Date of Patent: March 10, 2009
    Assignee: Mitsubishi Tanabe Pharma Corporation
    Inventors: Masakazu Fujio, Hiroyuki Satoh, Shinya Inoue, Toshifumi Matsumoto, Yasuhiro Egi, Taichi Takahashi
  • Publication number: 20060094743
    Abstract: The present invention relates to an isoquinoline compound represented by the following formula (I) or (II), an optically active form thereof, a pharmaceutically acceptable salt thereof, a water adduct thereof, a hydrate thereof and a solvate thereof, as well as an agent for the prophylaxis and/or treatment of a disease caused by hyperreactivity of poly(ADP-ribose)polymerase, containing the compound, and a poly(ADP-ribose)polymerase inhibitor containing the compound. In addition, this compound is useful as an agent for the prophylaxis and/or treatment of cerebral infarction, particularly as an agent for the prophylaxis and/or treatment of acute cerebral infarction.
    Type: Application
    Filed: November 21, 2003
    Publication date: May 4, 2006
    Applicant: Mitsubishi Pharma Corporation
    Inventors: Masakazu Fujio, Hiroyuki Satoh, Shinya Inoue, Toshifumi Matsumoto, Yasuhiro Egi, Taichi Takahashi